Hep C drug clears next hurdle towards NICE approval
A treatment for people with chronic hepatitis C has been given draft approval for use in the NHS, after the drug’s manufacturer agreed to reduce the price.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units